A novel method for assessment of  transcription activation in vitro for bacterial promoter by Uppal, Sheetal et al.
Indian Journal of Experimental Biology 
Vol. 58, January 2020, pp. 69-73 
 
 
 
 
 
 
A novel method for assessment of  
transcription activation in vitro for  
bacterial promoter 
Sheetal Uppal*, Narendra Jawali & Hari Sharan Misra 
Molecular Biology Division, Bhabha Atomic Research Centre, 
Trombay, Mumbai-400 085, Maharashtra, India 
Received 05 February 2018; revised 13 December 2018 
In vitro transcription (IVT) assay is a useful tool to monitor the 
transcriptional activity of a specific promoter under defined 
conditions in vitro. Conventional IVT assay involves use of 
radiolabeled probes which makes it tedious to perform and limits 
its utility for large scale applications. Here, a reverse-
transcription-PCR (RT-PCR) based transcript detection method 
has been developed for bacterial in vitro transcription assay. 
Unlike conventional radiolabeling approach, this method is 
simple, fast, needs smaller reaction volumes, does not require 
special infrastructure and could be potentially used for any large-
scale screening applications. The present study demonstrates the 
feasibility of this method by showing Cyclic AMP Receptor 
Protein (CRP) mediated activation of a CRP dependent E. coli 
promoter. 
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In vitro transcription (IVT) assays are carried out to 
assess the ability of bacterial RNA polymerase to 
transcribe from a specific promoter or to probe 
differential transcription from a given promoter under 
different conditions e.g. in presence of a transcription 
factor. The components of a typical bacterial IVT 
assay include a ds-DNA template containing a 
promoter, ribonucleotide triphosphates (rNTPs), and 
bacterial RNA polymerase (RNAP) in appropriate 
buffer conditions. The conventional assays use 
radioactive probe to label the nascent transcript which 
necessitates appropriate infrastructure for safe 
storage, usage and disposal of radioactivity. To add to 
these problems are limited half-life of commonly used 
radiolabels, use of tedious denaturing PAGE gels for 
resolving the transcripts, longer exposure periods 
required for X-ray films or requirement of expensive 
instruments such as phosphorimager.  
In recent studies
1-3
, non-radioactive methods of 
labeling have been developed where detection is done 
by direct fluorescent staining of the newly synthesized 
transcript. However, these would also detect any non-
specific nucleic acid present in the reaction. 
Alternative non-radioactive methods involving 
incorporation of bulky modified rNTP does not seem 
to be promising as bacterial RNA polymerases do not 
incorporate these modified nucleotides efficiently 
(e.g. Dig-UTP or biotin-UTP by E. coli RNAP)
1
. 
Further, the necessity of purification during different 
stages of assay makes it tedious and vulnerable to 
losses. Moreover, in all the above approaches, the 
final handling material is RNA which is highly prone 
to degradation by RNases. RT-PCR is currently 
among the most sensitive methods of RNA detection 
and is widely used for semi-quantitation of RNA 
levels
4-7
. Here, we demonstrate a novel and better 
method for in vitro transcription (IVT) assays which 
uses Reverse transcription (RT)-PCR as an alternative 
to radiolabeling for IVT. The feasibility of this 
method has been demonstrated by evaluation of 
transcription activation of a Cyclic AMP Receptor 
Protein (CRP) dependent E. coli gene promoter in 
presence of purified CRP. 
 
Materials and Methods 
 
Template preparation for in vitro transcription assay  
Table.1 shows the list of primer sequences used in 
this study. CC (-41.5) promoter, a CRP-dependent 
promoter with consensus CRP-binding site centered at 
position -41.5 upstream of the melR gene, is fused to 
lac operon in pRW50 (a lac expression vector: tet
R
)
8
. 
CC (-41.5) promoter DNA fragment (~470 bp), 
comprising of 80 bp upstream and 266 bp 
downstream of melR gene fused to lac operon along 
with some plasmidic region, was PCR amplified using 
—————— 
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Table 1 — List of primers used in the study 
SU123F AGAGCCATCCATGAATACAGATACGTTTAT 
SU125F* ACCCGGGGATCAGGTAAA----------------
TGGATCCCCCCTCACTCCT 
SU126R* AGGAGTGAGGGGGGATCCA----------------
TTTACCTGATCCCCGGGT 
SU128F TTTCCAACGCGAGCCATTCGCGAGA 
SU129R GCAGGTCGTTGAACTGAGCCTGAAATTCA 
*position of CRP target site deletion is shown by dashed lines 
 
INDIAN J EXP BIOL, JANUARY 2020 
 
 
70 
pRW50 as a template and plasmid specific forward 
(SU128F) and reverse (SU129R) primers (as depicted 
in Fig. 1A). CC (Δ15) (~455 bp) was synthesized 
using overlap extension PCR method as described in 
previously
9
. The flanking primers (SU128F and 
SU129R) and the overlapping primers (SU125F and 
SU126R), carrying deletion of 15 bases spanning 
CRP target site, were used with pRW50 plasmid DNA 
as template (Fig. 1A). Final PCR products were 
purified using High pure PCR purification kit (Roche 
Molecular Biochemicals, Germany).  
 
Electrophoretic mobility shift assays (EMSA) 
EMSAs were carried out as described previously
9
. 
Recombinant CRP protein was purified as described 
previously
10
. Briefly, the DNA samples (PCR 
products) were mixed with 200 nM purified His-
tagged CRP protein in 10 μL of 1X binding buffer 
(100 mM KCl, 40 mM Tris-HCl [pH 8.0], 10 mM 
EDTA, 1 mM dithiothreitol [DTT], 200 μM cAMP, 
100 μg of bovine serum albumin/mL) and incubated 
at 37°C for 10 min. Samples were mixed with loading 
dye (bromophenol blue, 0.25%; xylene cyanol FF, 
0.25%; Ficoll 400, 15%) and loaded on to a 10% non-
denaturing polyacrylamide gel containing 200 μM 
cAMP (Sigma Aldrich, USA). The gel was 
electrophoresed at constant voltage (15 V/cm), stained 
in 1X SYBR green I nucleic acid gel stain (Roche 
Molecular Biochemicals, Germany), and visualized 
under UV light using gel documentation system 
(Syngene, UK).  
 
In vitro transcription reaction coupled with RT-PCR 
 
In vitro transcription  
IVT reactions were set up in 10 μL with 
appropriate DNA template at ~0.1 nM in a buffer 
containing 100 mM KCl, 40 mM Tris–HCl pH 8.0,  
6 mM MgCl2, 10 mM dithiothreitol (DTT), 2 mM 
spermidin, 50 μg/mL bovine serum albumin (BSA), 
200 μM cAMP, without or with 0.5 nM CRP. The 
reaction mixture was pre-incubated with 1 U of  
E. coli RNA polymerase Holoenzyme (USB, USA), 
16 units of RNase inhibitor (Protector RNase 
Inhibitor, Roche Molecular Biochemicals, Germany) 
and CRP (if present) at 37°C for 10 min followed by 
addition of NTPs (ATP, CTP, GTP, and UTP; 200 μM) 
(Roche Molecular Biochemicals, Germany) and 
further incubation at 37°C for 15 min. The buffer 
conditions and presence of additional supplements 
may vary for specific promoters. 
 
 
 
Fig. 1 — (A) A line diagram depicting the EcoRI-HindIII CC (-41.5) synthetic melR fragment (-80 to +266 bp) fused upstream of lac 
operon in pRW50. The position of all the primers is shown by an arrow. TSS (+1) used for PCC (-41.5) transcription is marked; (B) The plot 
of Ct value as a function of concentration (log axis) of CC (-41.5) PCR product (+13 to +266 using SU123F/SU129R primers) (0.000001 ng/μL 
to 1 ng/μL) for calculation of PCR efficiency. The trend line equation and R2 value are displayed; (C) Electrophoretic mobility shift 
assays (EMSA) showing CRP binding to CC (-41.5) and CC (Δ15) promoters; and  (D) In vitro transcription assays using Reverse 
transcription (RT)-PCR: Ethidium bromide stained agarose gel showing PCR products after in vitro transcription (IVT), and RT-PCR for 
CC (-41.5) (lane 1-3) and CC (Δ15) (lane 4-6) promoters in presence (lane 2, 5) and absence of CRP (lane 1,4), PCR products from No 
RT reactions for CC (-41.5) (lane 3) and CC (Δ15) (lane 6) are also included.  
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Reverse transcription 
As the RNA transcribed during IVT is finally 
detected by RT-PCR, any template DNA present may 
interfere and give rise to false positives during PCR. 
Therefore, it is necessary to remove the template 
DNA before proceeding for RT using DNase1 
treatment of the IVT sample. Template DNA was 
removed by treating 10 μL of IVT reaction with 10 
units of DNase1 (Roche Molecular Biochemicals, 
Germany) (final volume 20 μL), incubation at 37°C 
for 1 h followed by heat inactivation of DNase1 at 
65°C for 15 min. It should be noted here that no 
purification step or buffer exchange was performed 
preceding either DNase1 treatment or reverse 
transcription thereby minimizing the purification 
losses. Moreover, the efficiency of DNase treatment 
or downstream reverse transcription reaction was 
reasonably good in spite of the carryover from the 
IVT buffer.  
Following removal of the template DNA 
contamination, the RNA synthesized in vitro (2.5 μL) 
was converted to cDNA (reaction volume 10 μL) 
using a reverse primer (SU129R) complementary to 
downstream sequence present in the transcript and 
SuperScrpit II reverse transcriptase (Invitrogen, USA) 
as per the manufacturer’s instructions. A parallel 
reaction without RT was also set-up as a control to 
rule out any template DNA amplification (if there is 
inefficient DNasing) during PCR.  
 
PCR/Real Time PCR 
The Conventional PCR was performed using 1 μL 
of cDNA product (final volume 25 μL) in presence of 
both forward (SU123F) and reverse primers 
(SU129R) (Fig. 1A) using Paq5000 DNA polymerase 
(Agilent technologies, USA) with 25 cycles of 
denaturation (94°C for 30 s), annealing (60°C for 30 s), 
extension (72°C for 30 s). The same Reverse primer 
(SU129R) was used for template amplification, RT 
and PCR. The PCR products were run on a 1.5% 
ethidium bromide stained agarose gel. Image of the 
gel was captured under UV light using a gel 
documentation system (Syngene, UK). Intensity of 
DNA bands was quantified using ImageJ software 
(http://rsb.info.nih.gov/ij). Intensity of the PCR 
product was taken as a measure of the net transcript 
synthesized during IVT. The fold activation was 
expressed as a ratio of the intensity values in the 
presence and absence of CRP. The experiment was 
repeated at least three times and the results were 
found to be consistent.  
Real Time PCR reaction with 0.5X Syber Green 
was run in Real-Time PCR cycler (Rotor-Gene Q of 
Qiagen, Germany). Ct value (Threshold Cycle) is 
defined as the cycle number at which the PCR product 
crosses a threshold of detection where the threshold 
line was automatically set by the software algorithm 
of the instrument. A standard curve analysis was 
performed with PCR amplification using varying 
concentration (0.000001 ng/μL to 1 ng/μL) of CC  
(-41.5) DNA (+13 to +266) as template and 
SU123F/SU129R primers for estimation of the PCR 
efficiency (Fig. 1B). Standard curve was generated 
manually by plotting Ct values as a function of 
respective template DNA concentration (log axis) and 
then by fitting a logarithmic regression trend line. The 
PCR efficiency, as calculated from the slope of the 
trend line using following formula, was found to be 
1.998 (R
2
=1)
11 
(Fig. 1B): 
E=10
[-1/slope]
 
Subsequently, the Ct values obtained for individual 
RT-PCR samples were analyzed by REST analysis
11
 
to find out the fold regulation (R) using the following 
formula (Table 2): 
                    (Ecc) 
ΔCP
cc 
         R =                    
                    (EΔ15) 
ΔCP
 Δ15  
where, CC is CC (-41.5) and Δ15 is CC (Δ15), E is 
efficiency (same for both CC and Δ15) and ΔCP is 
the difference between the Ct values for the sample 
with no CRP and the sample with CRP.  
 
Results and Discussion 
The feasibility of in vitro transcription assay, 
coupled with RT-PCR was demonstrated by 
evaluation of transcription activation of a Cyclic AMP 
Receptor Protein (CRP) dependent E. coli gene 
promoter in presence of purified CRP. CRP, in 
presence of cAMP, regulates gene transcription by 
binding to a 22 base pair consensus sequence present 
in the upstream region of some of the E. coli 
promoters
12
. In this study, CC (-41.5) promoter, 
synthetic derivative of E. coli melR promoter with 
consensus CRP target site located at -41.5 with 
respect to the transcription start
8
, was used to measure 
 
Table 2 — Results from Real Time PCR using REST analysis11 
Promoter 
DNA 
Mean Ct values 
(CRP-) 
Mean Ct values 
(CRP+) 
Expression ratio 
(Based on Rest 
analysis) 
CC (-41.5) 23.515±0.235 21.215±0.115 
4.362±0.94204 CC (Δ15) 21.810±0.140 21.635±0.095 
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activation by CRP (Fig. 1A). CRP has been shown to 
bind and activate transcription from CC (-41.5) 
promoter both in vivo and in vitro
8
. CC (Δ15), with 
CRP target site (15 bp) deleted from CC (-41.5), was 
also used to reaffirm that the CRP target site is 
necessary for the activation. Purified PCR fragments 
CC (-41.5) and CC (Δ15), were used as template for 
in vitro transcription. Binding of CRP to the template 
fragments was checked using electrophoretic mobility 
shift assays (EMSA) (Fig. 1C). As expected, CC (-41.5), 
having CRP target site, showed binding to CRP (Fig. 1C, 
Lane 1-2) while CC (Δ15), with CRP target site deleted, 
did not show any binding (Lanes 3 & 4). 
IVT reaction products were subjected to reverse 
transcription (RT) after DNase treatment to get rid of 
template DNA contamination. RT products were 
evaluated by both conventional PCR and real time 
Syber green based PCR method. Here, the level of the 
PCR product was an indicative measure of the 
transcript produced during in vitro transcription. In 
line with the previous results based on conventional 
radiolabeling used for IVT
8
, both CC (-41.5) and CC 
(Δ15) promoters exhibited a basal level (in absence of 
CRP) of transcription as seen by the presence of a 
faint PCR product with RT (Fig. 1D, lane 1, 4). Absence 
of a PCR product in no RT sample (lanes 3 & 6) ruled 
out any template DNA contamination indicating that 
the DNase1 treatment was successful and the PCR 
product in the RT samples (lane 1, 2, 4, 5) is 
originating from the cDNA only. The RT-PCR 
product from the CC (-41.5) promoter showed an 
increase (~ 4 fold) in presence of CRP (lane 2) as 
compared to the levels in the absence of CRP (lane 1) 
indicating that CRP activates CC (-41.5) transcription. 
However, CC (Δ15) lacking the CRP target site, did 
not show any change in the RT-PCR product upon 
CRP addition (lanes 4 & 5) reaffirming that the CRP 
mediated activation for CC (-41.5) is mediated 
through binding of CRP to the target site. On the same 
lines, results from Real Time PCR showed a similar 
increase (4.36 ± 0.94 fold) for CC (-41.5) promoter in 
presence of CRP (Table 2) while CC (Δ15) did not 
show any increase. Hence, the results from IVT-RT-
PCR based assay were in line with already published 
results for CRP mediated CC (-41.5) activation using 
conventional radiolabeling
8
 and reaffirmed that CRP 
activates transcription from CC (-41.5) promoter by 
binding to the CRP target site. Though we have 
demonstrated the use of this method only for an  
E. coli promoter, it could be potentially used for any 
bacterial promoter
13-16
. Use of Real Time PCR makes 
this method amenable to scale-up and automation 
which have the potential to be used for large scale 
drug screening assays e.g. for discovering new class 
of bacterial RNA polymerase inhibitors
17-21
. 
 
Conclusion 
The present study is a proof of concept to show 
that RT-PCR based in vitro transcription assay could 
be used for qualitative assessment of the basal level of 
transcript as well as differential transcription from a 
bacterial promoter
 
in vitro. To summarize, the major 
advantages of this method over conventional radio-
labeling are that (i) it is less time consuming, simple 
and easy to perform; (ii) being non-radioactive, it 
does not need special infrastructure; (iii) cDNA being 
less prone to degradation than RNA, makes the 
handling easier; (iv) can be performed in very small 
volumes thereby reducing the reagent costs;  
(v) absence of any purification step minimizes the 
losses; and (vi) use of Real Time PCR makes this 
method amenable to scale-up and automation. 
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